AnalystsAndrew TsaiAndrew Tsai's Stock Forecasts
AnalystsAndrew Tsai
Analyst Ranking
Top 34%
#1550 out of 4554 analysts
Average Return
+5.76%
Win Rate
40%4 out of 10
Risk vs Reward
Poor
Good
Andrew Tsai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cerevel Therapeutics Holdings IncCERE | +139.30% | $14.20 | $33.98 | 2020-11-22 - 2021-11-22 | Strong Buy |
Xenon Pharmaceuticals IncXENE | +41.19% | $13.11 | $18.51 | 2020-05-31 - 2021-06-01 | Strong Buy |
Intra Cellular Therapies IncITCI | +33.63% | $35.30 | $47.17 | 2021-09-19 - 2022-09-19 | Strong Buy |
Ke Holdings IncBEKE | +15.58% | $14.89 | $17.21 | 2022-03-15 - 2023-03-15 | Strong Buy |
Andrew Tsai Analyst Color
Get additional color on Andrew Tsai's coverage of popular stocks
Andrew Tsai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Fusion Pharmaceuticals IncFUSN | 1 | Hold | $21.00 | -1.18% | Downgrades | a month ago |
Alto Neuroscience IncANRO | 1 | Strong Buy | $33.00 | +144.44% | Initiates Coverage On | 2 months ago |
Vistagen Therapeutics IncVTGN | 2 | Strong Buy | $15.00 | +219.15% | Upgrades | 4 months ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $3.00 | N/A | Initiates Coverage On | a year ago |
Athira Pharma IncATHA | 1 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Ke Holdings IncBEKE | 1 | Strong Buy | $16.00 | N/A | Upgrades | 2 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $70.00 | N/A | Maintains | 3 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 3 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $23.00 | N/A | Assumes | 4 years ago |
Relmada Therapeutics IncRLMD | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.